Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Science ; 316(5822): 201; author reply 201, 2007 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-17431155

RESUMEN

Turner et al. (Reports, 20 October 2006, p. 449) measured sedimentation from Hurricanes Katrina and Rita in coastal Louisiana and inferred that storm deposition overwhelms direct Mississippi River sediment input. However, their annualized hurricane deposition rate is overestimated, whereas riverine deposition is underestimated by at least an order of magnitude. Their numbers do not provide a credible basis for decisions about coastal restoration.

4.
South Med J ; 96(6): 544-7, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12938779

RESUMEN

BACKGROUND: Idiopathic hypogonadotropic hypogonadism (IHH) has been observed to occur in men with premature ejaculation (PE). Common IHH therapies include testosterone replacement, which increases testosterone levels but suppresses gonadotropin release; and gonadotropin-releasing hormone supplementation, which restores gonadotropin levels but is impractical for chronic use. Hormonal imbalances associated with IHH/PE are thought to be related to hyperactivity of the cytochrome P-450 enzyme aromatase. METHODS: Ten male patients with a diagnosis of IHH/PE were treated with the aromatase inhibitor anastrazole (1 mg/d orally). Levels of free and total testosterone, luteinizing hormone, follicle-stimulating hormone, prolactin, and estradiol were determined at baseline and after 2 weeks of therapy. RESULTS: After 2 weeks of therapy with anastrazole, levels of testosterone, luteinizing hormone, and estradiol had returned to normal. No effect was noted on premature ejaculation. CONCLUSION: These results suggest that aromatase inhibition with anastrazole may provide a practical and efficacious alternative for the treatment of IHH but is not effective in preventing premature ejaculation.


Asunto(s)
Inhibidores de la Aromatasa , Aromatasa/uso terapéutico , Eyaculación/efectos de los fármacos , Inhibidores Enzimáticos/uso terapéutico , Gonadotropinas/sangre , Hipogonadismo/sangre , Hipogonadismo/tratamiento farmacológico , Nitrilos/uso terapéutico , Triazoles/uso terapéutico , Adulto , Anastrozol , Índice de Masa Corporal , Estradiol/sangre , Estudios de Seguimiento , Hormonas Esteroides Gonadales/sangre , Humanos , Hipogonadismo/complicaciones , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Testosterona/sangre , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...